Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara G Chisari

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neurology and Therapy|October 9, 2021
Multiple Sclerosis, COVID-19 and Vaccines: Making the PointSimona Toscano, Clara G Chisari, Francesco Patti
Frontiers in Neurology|February 23, 2018
Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and TreatmentAlessandro Serra, Clara G Chisari, Manuela Matta
Expert Opinion on Drug Metabolism & Toxicology|January 25, 2018
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosisFrancesco Patti, Clara G Chisari, Emanuele D'Amico, et al.
Current Clinical Pharmacology|July 6, 2017
Aging Eye Microbiota in Dry Eye Syndrome in Patients Treated with <i>Enterococcus faecium</i> and <i>Saccharomyces boulardii</i>Giuseppe Chisari, Eleonora M Chisari, Antonio M Borzi, et al.
BMC Neurology|November 29, 2021
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case seriesClara G Chisari, Simona Toscano, Sebastiano Arena, et al.
Expert Opinion on Pharmacotherapy|May 16, 2019
Pharmacoeconomics of synthetic therapies for multiple sclerosisEmanuele D'Amico, Clara G Chisari, Lara Gitto, et al.
Expert Opinion on Pharmacotherapy|April 29, 2020
An update on the pharmacological management of pain in patients with multiple sclerosisClara G Chisari, Eleonora Sgarlata, Sebastiano Arena, et al.
Infectious Disorders Drug Targets|April 12, 2018
Microbiological Etiology of Chronic Skin Lesions in Type 2 Diabetic SubjectsGiuseppe Chisari, Laura M Chisari, Antonio M Borzì, et al.
Expert Opinion on Drug Safety|August 21, 2019
An update on the safety of treating relapsing-remitting multiple sclerosisClara G Chisari, Simona Toscano, Emanuele D'Amico, et al.
Journal of Neurology|December 29, 2016
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomographyEster Reggio, Clara G Chisari, Giulia Ferrigno, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neurology and Therapy|October 9, 2021
Multiple Sclerosis, COVID-19 and Vaccines: Making the PointSimona Toscano, Clara G Chisari, Francesco Patti
Frontiers in Neurology|February 23, 2018
Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and TreatmentAlessandro Serra, Clara G Chisari, Manuela Matta
Expert Opinion on Drug Metabolism & Toxicology|January 25, 2018
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosisFrancesco Patti, Clara G Chisari, Emanuele D'Amico, et al.
Current Clinical Pharmacology|July 6, 2017
Aging Eye Microbiota in Dry Eye Syndrome in Patients Treated with <i>Enterococcus faecium</i> and <i>Saccharomyces boulardii</i>Giuseppe Chisari, Eleonora M Chisari, Antonio M Borzi, et al.
BMC Neurology|November 29, 2021
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case seriesClara G Chisari, Simona Toscano, Sebastiano Arena, et al.
Expert Opinion on Pharmacotherapy|May 16, 2019
Pharmacoeconomics of synthetic therapies for multiple sclerosisEmanuele D'Amico, Clara G Chisari, Lara Gitto, et al.
Expert Opinion on Pharmacotherapy|April 29, 2020
An update on the pharmacological management of pain in patients with multiple sclerosisClara G Chisari, Eleonora Sgarlata, Sebastiano Arena, et al.
Infectious Disorders Drug Targets|April 12, 2018
Microbiological Etiology of Chronic Skin Lesions in Type 2 Diabetic SubjectsGiuseppe Chisari, Laura M Chisari, Antonio M Borzì, et al.
Expert Opinion on Drug Safety|August 21, 2019
An update on the safety of treating relapsing-remitting multiple sclerosisClara G Chisari, Simona Toscano, Emanuele D'Amico, et al.
Journal of Neurology|December 29, 2016
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomographyEster Reggio, Clara G Chisari, Giulia Ferrigno, et al.
Pageof 2